 Vanessa Phelan
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 10 | 2024 | 359 | 2.560 |
Why?
| | Tandem Mass Spectrometry | 7 | 2025 | 566 | 1.120 |
Why?
| | Biofilms | 4 | 2022 | 276 | 1.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2022 | 144 | 0.970 |
Why?
| | Software | 5 | 2025 | 682 | 0.900 |
Why?
| | Culture Media | 3 | 2022 | 163 | 0.890 |
Why?
| | Metabolomics | 5 | 2025 | 712 | 0.880 |
Why?
| | Secondary Metabolism | 1 | 2024 | 6 | 0.860 |
Why?
| | Genome, Bacterial | 1 | 2024 | 152 | 0.770 |
Why?
| | Molecular Imaging | 1 | 2022 | 55 | 0.710 |
Why?
| | Biological Products | 4 | 2020 | 243 | 0.690 |
Why?
| | Microbiota | 4 | 2022 | 756 | 0.660 |
Why?
| | Cystic Fibrosis | 5 | 2024 | 1132 | 0.650 |
Why?
| | Sputum | 2 | 2021 | 311 | 0.640 |
Why?
| | Mass Spectrometry | 5 | 2025 | 738 | 0.620 |
Why?
| | Phylogeny | 1 | 2024 | 1003 | 0.610 |
Why?
| | Pseudomonas Infections | 4 | 2024 | 225 | 0.510 |
Why?
| | Computational Biology | 2 | 2020 | 673 | 0.470 |
Why?
| | Bacterial Proteins | 4 | 2021 | 935 | 0.440 |
Why?
| | Azithromycin | 1 | 2015 | 99 | 0.430 |
Why?
| | Mutagenesis, Insertional | 1 | 2014 | 65 | 0.420 |
Why?
| | Coinfection | 4 | 2023 | 133 | 0.400 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 120 | 0.390 |
Why?
| | Metabolome | 3 | 2024 | 373 | 0.360 |
Why?
| | Web Browser | 2 | 2022 | 13 | 0.340 |
Why?
| | Bacteria | 3 | 2012 | 881 | 0.320 |
Why?
| | Peptide Synthases | 1 | 2009 | 3 | 0.310 |
Why?
| | Diphosphates | 1 | 2009 | 19 | 0.310 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2009 | 31 | 0.300 |
Why?
| | Agar | 2 | 2022 | 11 | 0.280 |
Why?
| | Staphylococcal Infections | 2 | 2023 | 395 | 0.260 |
Why?
| | Adenosine Triphosphate | 1 | 2009 | 485 | 0.250 |
Why?
| | Programming Languages | 1 | 2025 | 25 | 0.230 |
Why?
| | Anthramycin | 3 | 2009 | 3 | 0.220 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1881 | 0.210 |
Why?
| | Data Mining | 1 | 2025 | 117 | 0.210 |
Why?
| | Glycolipids | 1 | 2024 | 49 | 0.200 |
Why?
| | Multigene Family | 4 | 2013 | 204 | 0.200 |
Why?
| | Plankton | 1 | 2022 | 7 | 0.200 |
Why?
| | Metabolic Networks and Pathways | 2 | 2024 | 185 | 0.190 |
Why?
| | Bioreactors | 1 | 2022 | 49 | 0.190 |
Why?
| | Chromatography, Liquid | 2 | 2015 | 453 | 0.190 |
Why?
| | Indicators and Reagents | 1 | 2022 | 108 | 0.180 |
Why?
| | Microbial Interactions | 3 | 2021 | 18 | 0.180 |
Why?
| | Principal Component Analysis | 1 | 2021 | 197 | 0.170 |
Why?
| | Alginates | 1 | 2020 | 47 | 0.160 |
Why?
| | Genomic Library | 1 | 2019 | 17 | 0.160 |
Why?
| | Staphylococcus aureus | 2 | 2023 | 443 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 325 | 0.150 |
Why?
| | Genomics | 1 | 2024 | 820 | 0.140 |
Why?
| | Workflow | 1 | 2020 | 177 | 0.140 |
Why?
| | Metagenomics | 1 | 2019 | 180 | 0.140 |
Why?
| | Databases, Factual | 2 | 2020 | 1458 | 0.130 |
Why?
| | Molecular Structure | 2 | 2016 | 503 | 0.130 |
Why?
| | Health | 1 | 2017 | 83 | 0.130 |
Why?
| | Databases, Chemical | 1 | 2016 | 9 | 0.130 |
Why?
| | Disease | 1 | 2017 | 98 | 0.120 |
Why?
| | Data Curation | 1 | 2016 | 19 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 546 | 0.120 |
Why?
| | Xenobiotics | 1 | 2015 | 32 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1821 | 0.120 |
Why?
| | Humans | 16 | 2025 | 142526 | 0.110 |
Why?
| | Phenazines | 1 | 2014 | 12 | 0.110 |
Why?
| | Information Dissemination | 1 | 2016 | 210 | 0.110 |
Why?
| | Open Reading Frames | 2 | 2011 | 133 | 0.100 |
Why?
| | Quinolones | 1 | 2015 | 177 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2013 | 56 | 0.100 |
Why?
| | Animals | 7 | 2023 | 37697 | 0.100 |
Why?
| | Candida albicans | 1 | 2013 | 59 | 0.100 |
Why?
| | ras Proteins | 1 | 2013 | 145 | 0.090 |
Why?
| | Tubulin | 1 | 2013 | 145 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 371 | 0.090 |
Why?
| | Ribosemonophosphates | 1 | 2010 | 1 | 0.090 |
Why?
| | Bacillus cereus | 1 | 2010 | 5 | 0.090 |
Why?
| | Glucose-6-Phosphate | 1 | 2010 | 6 | 0.090 |
Why?
| | Phosphotransferases | 1 | 2010 | 25 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2012 | 590 | 0.080 |
Why?
| | Hemeproteins | 1 | 2010 | 8 | 0.080 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 146 | 0.080 |
Why?
| | Plasmodium | 1 | 2010 | 12 | 0.080 |
Why?
| | Antimalarials | 1 | 2010 | 33 | 0.080 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2008 | 133 | 0.080 |
Why?
| | Oxygen Radioisotopes | 1 | 2009 | 2 | 0.080 |
Why?
| | ortho-Aminobenzoates | 1 | 2009 | 10 | 0.080 |
Why?
| | Malaria | 1 | 2010 | 67 | 0.080 |
Why?
| | Biocatalysis | 1 | 2009 | 69 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2013 | 567 | 0.070 |
Why?
| | Genes, Synthetic | 1 | 2008 | 14 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2009 | 178 | 0.070 |
Why?
| | High-Throughput Screening Assays | 1 | 2010 | 158 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2013 | 558 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 643 | 0.070 |
Why?
| | Streptomyces | 1 | 2007 | 8 | 0.070 |
Why?
| | Ecosystem | 1 | 2011 | 579 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1262 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1626 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 1054 | 0.060 |
Why?
| | Oligopeptides | 1 | 2006 | 266 | 0.060 |
Why?
| | Phenotype | 1 | 2011 | 3184 | 0.050 |
Why?
| | Thiazoles | 1 | 2023 | 134 | 0.050 |
Why?
| | Phenols | 1 | 2023 | 113 | 0.050 |
Why?
| | Species Specificity | 2 | 2012 | 574 | 0.040 |
Why?
| | Internet | 1 | 2025 | 694 | 0.040 |
Why?
| | Respiratory System | 1 | 2021 | 156 | 0.040 |
Why?
| | Benchmarking | 1 | 2019 | 181 | 0.040 |
Why?
| | Cosmids | 2 | 2008 | 6 | 0.030 |
Why?
| | Mice | 3 | 2023 | 18172 | 0.030 |
Why?
| | Algorithms | 1 | 2024 | 1791 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2916 | 0.030 |
Why?
| | Database Management Systems | 1 | 2016 | 51 | 0.030 |
Why?
| | Internationality | 1 | 2016 | 156 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2016 | 120 | 0.030 |
Why?
| | Ceramides | 1 | 2015 | 117 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 421 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 369 | 0.030 |
Why?
| | Adenovirus E1A Proteins | 1 | 2013 | 12 | 0.030 |
Why?
| | Bacillus | 1 | 2013 | 17 | 0.030 |
Why?
| | Pseudomonas | 1 | 2013 | 31 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.030 |
Why?
| | Genes, ras | 1 | 2013 | 94 | 0.020 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 548 | 0.020 |
Why?
| | Streptomyces coelicolor | 1 | 2013 | 3 | 0.020 |
Why?
| | Hyphae | 1 | 2013 | 11 | 0.020 |
Why?
| | Taxoids | 1 | 2013 | 105 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2013 | 93 | 0.020 |
Why?
| | Oncogenes | 1 | 2013 | 119 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 248 | 0.020 |
Why?
| | Microbiological Techniques | 1 | 2012 | 33 | 0.020 |
Why?
| | Aspergillus fumigatus | 1 | 2012 | 25 | 0.020 |
Why?
| | Fluorouracil | 1 | 2013 | 208 | 0.020 |
Why?
| | Ions | 1 | 2012 | 67 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 334 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2013 | 68 | 0.020 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 162 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2012 | 67 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2013 | 716 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 727 | 0.020 |
Why?
| | Cisplatin | 1 | 2013 | 328 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 914 | 0.020 |
Why?
| | Manganese | 1 | 2010 | 56 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 857 | 0.020 |
Why?
| | Actinobacteria | 1 | 2010 | 16 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 622 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2010 | 224 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1284 | 0.020 |
Why?
| | Catalysis | 1 | 2010 | 322 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2013 | 522 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2010 | 91 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2010 | 487 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2150 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1727 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2180 | 0.020 |
Why?
| | Peptides | 1 | 2013 | 974 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2008 | 205 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2007 | 165 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2008 | 338 | 0.020 |
Why?
| | Organophosphonates | 1 | 2006 | 97 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2007 | 333 | 0.010 |
Why?
| | Gene Deletion | 1 | 2007 | 385 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3546 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1051 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1728 | 0.010 |
Why?
| | Prognosis | 1 | 2013 | 4112 | 0.010 |
Why?
| | Base Sequence | 1 | 2008 | 2176 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2006 | 334 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1806 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4483 | 0.010 |
Why?
| | Lung | 1 | 2015 | 4078 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5967 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7006 | 0.010 |
Why?
| | Signal Transduction | 1 | 2013 | 5163 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 22326 | 0.010 |
Why?
| | Male | 2 | 2013 | 70910 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 35049 | 0.010 |
Why?
| | Female | 1 | 2013 | 76624 | 0.000 |
Why?
|
|
Phelan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|